VN July 2021
Vetnews | July 2021 11 Prognosis & Outcome At one week after discharge, Louie’s owner reported he had marked improvement in coughing (i.e., ≈80% reduction) and increased energy; however, his owner also noted Louie had excessive thirst, urination, and appetite. At two weeks, his owner reported intermittent coughing and persistent signs of corticosteroid excess. At one month after discharge, thoracic radiography was repeated and revealed marked improvement in diffusion of the bronchointerstitial pattern (Figure 4). Prednisone was tapered over the next 6 weeks to 10 mg every other day. Intermittent coughing returned, and the dosage was increased to 10 mg once daily (0.33 mg/kg/day), which maintained clinical control. Because this regimen did not result in significant adverse effects and maintained clinical control, adjunctive or alternative anti-inflammatory medications were not prescribed. Louie was managed on a low dose of prednisone (10 mg once daily) for 5 years with no complications. The primary care clinician attempted to taper prednisone but was unsuccessful—coughing returned as the frequency of medication was reduced. Discussion EBP (historically known as pulmonary infiltrates with eosinophils) is a disease characterised by eosinophilic infiltration of lung and bronchial mucosa and an important differential diagnosis for patients presented with chronic cough, acute onset of respiratory distress, and/or exercise intolerance.1,2 Cough is typically harsh and may be associated with gagging and retching. This disease can be seen at any age; however, dogs 4 to 6 years of age are most commonly represented. 1-3 Although Siberian huskies and Alaskan malamutes may be overrepresented, 2 the disease can occur in any dog breed. Physical examination findings may reveal abnormal lung sounds, but auscultation can be normal. 1,2 In addition, ≤24% of patients may have concurrent nasal discharge. 1,2,4 Diagnosis requires strong clinical suspicion, as EBP is an uncommon cause of the primary clinical signs (i.e., coughing, gagging, exercise intolerance). CBC may reveal an inflammatory leukogram (e.g., eosinophilia, neutrophilia) in ≤60% of cases. 4 Eosinophilia may raise clinical suspicion, but its absence does not rule out disease, as it is only present in 50% to 60% of cases. 1,2,5 Thoracic radiographs are generally characterised by a diffuse bronchointerstitialpatternwithperibronchialcuffingandthickening of the bronchial walls. In some cases, bronchiectasis or alveolar infiltration may be observed. 2,6-8 Occasionally, patchy pulmonary opacities create a nodular appearance. 4 Radiography is critical for ruling out other common causes of cough and/or acute respiratory distress. Concurrent disease processes (e.g., cardiomegaly, tracheal collapse) can complicate diagnosis. EBP on thoracic computed tomography has been characterised by parenchymal abnormalities (93%) and bronchial wall thickening (87%) in most dogs. Many dogs also had mucus and/or debris that occluded the bronchial lumen (73%), lymphadenopathy (67%), or bronchiectasis (60%). 9 Approximately 33% of dogs had pulmonary nodules, as has been identified on radiographs. 4,9 Cytologic evaluation of the airways confirms eosinophilic inflammation, which is the hallmark of diagnosis. TREATMENT AT A GLANCE • Treatment should be provided for parasitic disease if necessary (ie, fenbendazole 50 mg/kg every 24 hours for 10 to 14 days. • Prednisone should be initiated at 1 to 2 mg/kg/day. • Prednisone should be tapered gradually, ideally every 1 to 2 weeks to the lowest effective dose. • Clinical signs should be monitored, and regular communication with the pet owner is recommended. • Radiography should be repeated to assess the patient’s response to treatment. • Relapse is common, and long-term therapy may be necessary. • Steroid adverse effects should be minimized; if these are excessive, alternative medications may include other immunosuppressants (eg, cyclosporine, azathioprine) and/or inhaled corticosteroids (eg, fluticasone, beclomethasone). FIGURE 4 Radiograph 1 month after therapeutic initiation showing an improved bronchointerstitial pattern Article >>> 12
Made with FlippingBook
RkJQdWJsaXNoZXIy OTc5MDU=